Patient advocacy collaboration needs: breaking down barriers in patient access to secure success for cell and gene therapies in the real world
Immuno-Oncology Frontiers Europe
- The perfect collaboration: How do you create a strong relationship with patient advocacies?
- What is need to know for the patient about ATMPs? Can the field do more to educate these patients- if so what is the best way to approach this?
- What are patient advocacies expectations from pharma/biotech/academia in the R&D setting? What is the best package the cell and gene therapy industry can bring to the patient to ensure the therapy is brought to market faster?
- What information do they expect from the regulatory authorities?